MoneyWorks4Me

Clarification sought from Wockhardt

10 Sep 2015 Evaluate

The Exchange had sought clarification from Wockhardt with respect to news appearing in moneycontrol website & CNBCTV18 on September 9, 2015 titled ‘Wockhardt shares rise 5% on USFDA nod for alzheimer drug.’ Wockhardt response is enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1782.00
Dr. Reddys Labs. 1208.00
Cipla 1334.00
Lupin 2010.00
Zydus Lifesciences 1138.50
View more..